Cite
HARVARD Citation
Younossi, Z. et al. (2018). Sofosbuvir and velpatasvir with or without voxilaprevir in direct‐acting antiviral‐naïve chronic hepatitis C: patient‐reported outcomes from POLARIS 2 and 3. Alimentary pharmacology & therapeutics. 47 (2), pp. 259-267. [Online].